New Jersey Bill Requires Automatic Enrollment in State Electronic Vaccine Tracking Registry

Lawmakers in New Jersey have approved legislation that would require enrollment in the state’s electronic vaccine tracking registry, unless citizens actively opt out in writing. The bill for an “opt-out” vaccine tracking system, rather than operating an “opt-in” system, comes in response to decreased vaccination rates in recent years and health officials maintain it will […]
CDC Vaccine Advisory Panel Purged

On June 9, 2025, U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. fired all 17 members of the U.S. Centers for Disease Control and Prevention’s (CDC) committee that makes national vaccine policy—the Advisory Committee on Immunization Practices (ACIP). “A clean sweep is necessary to reestablish public confidence in vaccine science,” Secretary Kennedy […]
FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants

The U.S. Food and Drug Administration (FDA) has licensed Sanofi’ SA’s four-valent MenQuadfi meningococcal vaccine for use in infants aged six weeks to 23 months old to prevent invasive meningococcal disease. Previously approved for children aged two and older, MenQuadfi is now the first meningococcal vaccine included on the U.S. Centers for Disease Control and […]
FDA Licenses Moderna’s mNEXSPIKE COVID Shot for Individuals at High Risk for Severe COVID Disease

On May 30, 2025, the U.S. Food and Drug Administration (FDA) licensed mNEXSPIKE (mRNA-1283), a newly developed mRNA COVID-19 biologic for individuals who have previously received any COVID shots and are either 65 years of age or older, or between 12 and 64 years old with at least one underlying medical condition that increases their […]
Media Blatantly Misinforms the Public on COVID Vaccination

In a video post on the social media platform X on May 27, 2025, U.S. Secretary of Health and Human Services (HHS) Robert F. Kennedy, Jr. stated: The COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule. Last year, the Biden administration urged healthy children to […]
FDA Approves Novavax’s COVID-19 Vaccine With Restrictions

On May 16, 2025, the U.S. Food and Drug Administration (FDA) approved licensure of Novavax, Inc.’s Nuvaxovid protein-based COVID-19 vaccine, which has been available in the United States under Emergency Use Authorization (EUA) since July 2022.1 The decision for a full licensure was postponed while the new agency leadership under the current administration conducted a […]